Koyfin Home > Directory > Health Care > Adverum Biotechnlgs > Market Cap

Adverum Biotechnlgs Market Cap Chart (ADVM)

Adverum Biotechnlgs annual/quarterly Market Cap from 2014 to 2020. Market capitalization (market cap) is the market value of a publicly traded company's outstanding shares. Market capitalization is equal to the share price multiplied by the number of shares outstanding.
  • Adverum Biotechnlgs Market Cap for the quarter ending October 10, 2020 was $1,196m a 5.94% increase of 71m year over year
  • Adverum Biotechnlgs Market Cap for the last 12 months ending October 10, 2020 was $1,196m a 5.94% increase of 71m year over year
  • Adverum Biotechnlgs Annual Market Cap for 2020 was $1,196m a 4.96% increase of 59m from 2019
  • Adverum Biotechnlgs Annual Market Cap for 2020 was $1,137m a 0.09% increase of 1m from 2019
  • Adverum Biotechnlgs Annual Market Cap for 2020 was $1,136m a 0.94% increase of 11m from 2019
Other Valuation Metrics:
  • Adverum Biotechnlgs Price / Book for the quarter ending March 03, 2018 was 1.54 a 65.62% increase of 1.01 year over year
  • Adverum Biotechnlgs Enterprise Value for the quarter ending March 03, 2018 was $170m a 160.05% increase of 273m year over year
View Chart On Koyfin

Quarterly ADVM Market Cap Data

10/2020$1,196m
10/2020$1,137m
10/2020$1,136m
10/2020$1,125m
10/2020$1,200m
10/2020$1,174m
10/2020$1,154m
10/2020$1,140m
10/2020$1,095m
10/2020$1,084m

Annual ADVM Market Cap Data

2020$1,196m
2020$1,137m
2020$1,136m
2020$1,125m
2020$1,200m
2020$1,174m
2020$1,154m
2020$1,140m
2020$1,095m
2020$1,084m